Skip to main content
. 2022 Feb 10;12:2246. doi: 10.1038/s41598-022-06166-y

Figure 1.

Figure 1

Prevalence of neurocognitive, pain and mood symptoms in seronegative and seropositive study participants (Fisher’s exact test: n = 1504, * p < .05).